The physiological structure of human C-reactive protein and its complex with phosphocholine

Structure

Volumn 7, Issue 2, 1999, Pages 169-177

  Thompson, Darren ^a   Pepys, Mark B ^b   Wood, Steve P ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Acute phase response; Apoptosis; C reactive protein; C1q; Phosphocholine; Serum amyloid P component

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1Q; PHOSPHORYLCHOLINE;

ACUTE PHASE RESPONSE; APOPTOSIS; ARTICLE; BINDING SITE; HUMAN; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN LIPID INTERACTION;

EID: 0033081409     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(99)80023-9     Document Type: Article

References (55)

1. 1. Pepys, M.B. & Baltz, M.L. (1983). Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol. 34, 141-212.
2. 2. Pepys, M.B. (1995). The acute phase response and C-reactive protein. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine. Third ed. Oxford: Oxford University Press, 1527-1533.
3. 3. Pepys, M.B., Dash, A.C., Fletcher, T.C., Richardson, N., Munn, E.A. & Feinstein, A. (1978). Analogues in other mammals and in fish of human plasma proteins C-reactive protein and amyloid P component. Nature 273, 168-170.
4. 4. Pepys, M.B. (1994). Amyloidosis. In: Samter's Immunologic Diseases. Fifth ed. (Frank, M.M., Austen, K.F., Claman, H.N., Unanue, E.R., eds), pp. 637-655, Little, Brown and Company, Boston.
5. 5. Pepys, M.B., Booth, D.R., Hutchinson, W.L., Gallimore, J.R., Collins, P.M. & Hohenester, E. (1997). Amyloid P component. A critical review. Amyloid Int. J. Exp. Clin. Invest. 4, 274-295.
6. 6. Volanakis, J.E. & Kaplan, M.H. (1971). Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc. Soc. Exp. Biol. Med. 136, 612-614.
7. 7. Du Clos, T.W. (1989). C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J. Immunol. 143, 2553-2559.
8. 8. Pepys, M.B., Booth, S.E., Tennent, G.A., Butler, P.J.G. & Williams, D.G. (1994). Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli. Clin. Exp. Immunol. 97, 152-157.
9. 9. Liuzzo, G., et al., & Maseri, A. (1994). The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N. Engl. J. Med. 331, 417-424.
10. 10. Thompson, S.G., Kienast, J., Pyke, S.D.M., Haverkate, F. & van de Loo, J.C.W. (1995). Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N. Engl. J. Med. 332, 635-641.
11. 11. Kuller, L.H., Tracy, R.P., Shaten, J. & Meilahn, E.N. (1996). Relation of C-reactive protein and coronary heart-disease in the MRFIT nested case control study. Am. J. Epidemiol. 144, 537-547.
12. 12. Tracy, R.P., Kuller, L.H., Psaty, B.M., Cushman, M., Meilahn, E.N. & Smith, N. (1996). C-reactive protein and incidence of cardiovascular disease in older women: the rural health promotion project and the cardiovascular health study. Circulation 93, 622.
13. 13. Haverkate, F., Thompson, S.G., Pyke, S.D.M., Gallimore, J.R. & Pepys, M.B. (1997). Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349, 462-466.
14. 14. Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P. & Hennekens, C.H. (1997). Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336, 973-979.
15. 15. Koenig, W., et al., & Pepys, M.B. (1997). C-reactive protein (CRP) predicts risk of coronary heart disease (CHD) in healthy middle-aged men: results from the MONICA-Augsburg Cohort Study, 1984/85-1992. Circulation 96 (suppl. 1), 1-99.
16. 16. Volanakis, J.E. & Kaplan, M.H. (1974). Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea-pig complement by CRP complexes: requirement for human Clq. J. Immunol. 113, 9-17.
17. 17. Kaplan, M.H. & Volanakis, J.E. (1974). Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J. Immunol. 112, 2135-2147.
18. 18. Siegel, J., Rent, R. & Gewurz, H. (1974). Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera. J. Exp. Med. 140, 631-647.
19. 19. Volanakis, J.E. (1982). Complement activation by C-reactive protein complexes. Ann. N.Y. Acad. Sci. 389, 235-250.
20. 20. Jiang, H., Robey, F.A. & Gewurz, H. (1992). Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain. J. Exp. Med. 175, 1373-1379.
21. 21. Cermak, J., Key, N.S., Bach, R.R., Balla, J., Jacob, H.S. & Vercellotti, G.M. (1993). C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82, 513-520.
22. 22. Nakagomi, A., Freedman, S.B., Lau, W. & Geczy, C.L (1996). Procoagulant induction on human monocytes by proinflammatory stimulants is amplified by C-reactive protein and interferon-γ. Circulation 8, 4063.
23. 23. Ramani, M., Khechai, F., Ollivier, V., Ternisien, C., Bridey, F. & de Prost, D. (1995). Interleukin-10 and pentoxifylline inhibit C-reactive protein-induced tissue factor gene expression in peripheral human blood monocytes. Thromb. Haem. 73, 1082.
24. 24. McCarty, M. (1947). The occurrence during acute infections of a protein not normally present in the blood. IV. Crystallization of the C-reactive protein. J. Exp. Med. 85, 491-498.
25. 25. DeLucas, L.J., et al., & Bugg, C.E. (1987). Preliminary X-ray study of crystals of human C-reactive protein. J. Mol. Biol. 196, 741-742.
26. 26. Shrive, A.K., et al., & Greenhough, T.J. (1996). Three-dimensional structure of human C-reactive protein. Nat. Struct. Biol. 3, 346-354.
27. 27. Emsley, J., et al., & Wood, S.P. (1994). Structure of pentameric human serum amyloid P component. Nature 367, 338-345.
28. 28. Srinivasan, N., White, H.E., Emsley, J., Wood, S.P., Pepys, M.B. & Blundell, T.L. (1994). Comparative analyses of pentraxins: implications for protomer assembly and ligand binding. Structure 2, 1017-1027.
29. 29. Ashton, A.W., Boehm, M.K., Gallimore, J.R., Pepys, M.B. & Perkins, S.J. (1997). Pentameric and decameric structures in solution of serum amyloid P component by X-ray and neutron scattering and molecular modelling analyses. J. Mol. Biol. 272, 408-422.
30. 30. Agrawal, A. et al., & Volanakis, J.E. (1997). Site directed mutagenesis of the phosphocholine binding site of human C-reactive protein - role of Thr (76) and Trp (67) J. Immunol. 158, 345-350.
31. 31. CCP4 Collaborative Computational Project, Number 4, (1994). Acta Cryst. D 50, 760.
32. 32. Kinoshita, C.M., et al., & Gewurz, H. (1989). Elucidation of a protease sensitive site involved in the binding of calcium to C-reactive protein. Biochemistry 28, 9840-9848.
33. 33. Roux, K.H., Kilpatrick, J.M., Volanakis, J.E. & Kearney, J.F. (1983). Localization of the phosphocholine-binding sites on C-reactive protein by immunoelectron microscopy. J. Immunol. 131, 2411 -2415.
34. 34. Tennent, G.A., et al., & Pepys, M.B. (1993). Studies of the structure and binding properties of hamster female protein. Immunology 80, 645-651.
35. 35. Hohenester, E., et al., & Wood, S.W. (1997). Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP. J. Mol. Biol. 269, 570-578
36. 2 and C reactive protein in the removal of injured cells. Immunology Today 18, 111-115.
37. 37. Vigushin, D.M., Pepys, M.B. & Hawkins, P.N. (1993). Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J. Clin. Invest. 91, 1351-1357.
38. 38. Kushner, I. & Kaplan, M.H. (1961 ). Studies of acute phase protein. I. An immunohistochemical method for the localization of Cx-reactive protein in rabbits. Association with necrosis in local inflammatory lesions. J. Exp. Med. 114, 961 -973.
39. 39. Kushner, I., Rakita, L. & Kaplan, M.H. (1963). Studies of acute phase protein. II. Localization of Cx-reactive protein in heart in induced myocardial infarction in rabbits. J. Clin. Invest. 42, 286-292.
40. 40. Nakayama, S., Du Clos, T.W., Gewurz, H. & Mold, C. (1984). Inhibition of antibody responses to phosphocholine by C-reactive protein. J. Immunol. 132, 1336-1340.
41. 41. Pepys, M.B. & Butler, P.J.G. (1987). Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem. Biophys. Res. Commun. 148, 308-313.
42. 42. Pepys, M.B. (1998). C-reactive protein and amyloidosis: from proteins to drugs? The Lumleian Lecture. In Horizons in Medicine no. 10. (Williams G., ed.), Royal College of Physicians, London, in press.
43. 43. Pepys, M.B., Lanham, J.G. & de Beer, F.C. (1982). C-reactive protein in systemic lupus erythematosus. In Clinics in the Rheumatic Diseases. No. 1 (Hughes G.R.V., ed.), pp. 91-103, W.B. Saunders Co. Ltd, Eastbourne, UK,.
44. 44. Reichlin, M., Martin, A., Taylor-Albert, E., Tsuzuka, K., Zhang, W. & Reichlin, M.W. (1994). Lupus autoantibodies to native DNA cross-react with the A and D snRNP polypeptides. J. Clin. Invest. 93, 443-449.
45. 45. Leslie, A.G.W. (1992). Joint CCP4 and ESF-EACMB Newsletter on Protein Crystallography No. 26, Daresbury Laboratory, Warrington, UK.
46. 46. Brünger, A.T. (1992). X-PLOR Version 3.1: A system for X-Ray Crystallography and NMR. Yale University Press, New Haven, CT.
47. 47. Navaza, J. (1994). Amore - An automated package for molecular replacement. Acta Cryst. A 50, 157.
48. 48. Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. (1991). Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Cryst. A 47, 110-119.
49. 49. Laskowski, R.A., MacArthur, M.W., Moss, D.S. & Thornton, J.M. (1993). PROCHECK: a program to check the quality of protein structures. J. Appl. Cryst. 24, 946-950.
50. 50. Pigault, C., et al., & Brisson, A. (1994). Formation of two dimensional arrays of Annexin V on phosphatidylserine-containing liposomes. J. Mol. Biol. 236, 199-201.
51. 2+-binding motif in C2 domains of synaptotagmin and protein kinase C. Science 273, 248-251.
52. 2+ independent catalytic domain. J. Biol. Chem. 269, 18239-18244.
53. 2+-binding domains. J. Biol. Chem. 268, 27164-27170.
54. 2+-dependent conformational change in synaptotagrnin I. J. Biol. Chem. 269, 28547-28551.
55. 55. Bottazzi, B., et al., & Mantovani, A. (1997). Multimer formation and ligand recognition by the long pentraxin PTX3. J. Biol. Chem. 272, 32817-32823.